Dow Down 0.00% Nasdaq Down 0.05%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
9.95 Up 0.05(0.51%) 2:58PM EDT - Nasdaq Real Time Price
Prev Close:9.90
Open:9.89
Bid:9.89 x 11400
Ask:9.90 x 1800
1y Target Est:7.67
Beta:0.51
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:9.69 - 9.95
52wk Range:7.38 - 10.21
Volume:2,551,454
Avg Vol (3m):2,256,270
Market Cap:1.60B
P/E (ttm):5.73
EPS (ttm):1.74
Div & Yield:0.60 (6.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 0.51%1.60B
AMGNUp 0.13%104.40B
SGENUp 0.05%5.45B
XOMADown 2.27%460.43M

Key Statistics

Forward P/E (1 yr):4.41
P/S (ttm):3.62
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :1.98
Quarterly EPS Est (Sep-14) :0.50
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback